Sleep
Conditions
Brief summary
Recent studies in animal models have suggested a critical role for cerebrospinal fluid and Interstitial fluid flux through cerebral parenchyma for removal of byproducts of cellular metabolism and hence in maintaining the health of the brain. This effect is modulated during sleep, suggesting a potentially important mechanism for sleep to maintain both acute homeostasis and long-term cerebral health. The central goal of these studies is to develop a sensitive MRI biomarker of cerebral conformational changes during sleep. This exploratory work aims to establish the sensitivity and reproducibility of MRI as a non-invasive neuroimaging assessment of cerebral changes during natural sleep and sedation.
Detailed description
Recent studies in animal models have suggested a critical role for cerebrospinal fluid (CSF) / Interstitial fluid (ISF) flux through cerebral parenchyma for removal of byproducts of cellular metabolism and hence in maintaining the health of the brain. It remains unknown to what extent these phenomena exist in the human brain. A key challenge in this work is to make non-invasive and reproducible measurements of the cerebral microenvironment in humans. For these studies, the investigators have implemented a suite of MRI measurements to track physiological changes in the brain during sleep. This exploratory work aims to establish the sensitivity and reproducibility of MRI as a non-invasive neuroimaging assessment of cerebral changes during natural sleep and sedation. The long term goal of this work is to use MRI as an imaging biomarker to assess the cerebral response to normal versus disordered sleep in patients. Our specific aims will address the following questions: Aim 1: How sensitive are MRI metrics for determining changes in the brain during sleep? Aim 2: How reproducible are MRI metrics during sleep and during sedation? The investigators will recruit 12 normal adult subjects for this study (consecutive respondees to recruitment adverts). The investigators will make regional MRI measurements during onset, maintenance and waking from stage N2 sleep. From these the investigators will characterize which MRI metrics are most sensitive to changes in the cerebral environment, and how these vary for different cerebral regions. Measurements will be repeated during \ 90 minutes of natural sleep, and following oral sedation with 10 mg zaleplon (Sonata).
Interventions
DRUGZaleplon
Sleep Aid; 10mg; Oral; Single Use
OTHERNatural Sleep
Natural Sleep without medication
Sponsors
University of California, San Diego
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 59 Years
Inclusion criteria
* Healthy Adults
Exclusion criteria
1. age not in range 18-59 2. smoking / recreational drug use 3. pregnant women / breast feeding 4. contraindication to MRI 5. contraindications to Zaleplon 6. history of cardiovascular pulmonary or cerebral disease (hypertension (diastolic \>90 mmHg, systolic \> 150 mmHg), unstable cerebrovascular syndromes, prior history of cardiac arrhythmias, unstable angina, chronic obstructive pulmonary disease). 7. Current SSRI antidepressant medication 8. History of sleep disorder or currently taking sedative / stimulant medication
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Cerebral MRI Changes | 90 Minutes of Sleep | Change in MRI Signal from Awake Baseline |
Countries
United States
Outcome results
None listed